March 2018


In this Supplement

Advancing Endovascular Options

New Endovascular Devices and Insights to Extend Aortic Treatment to More Patients.



Download a PDF of this supplement

Early Experience Using the GORE® TAG® Conformable Thoracic Stent Graft With ACTIVE CONTROL System: Why It Is My Preferred TEVAR Device

A new TEVAR delivery system allows staged, predictable endograft deployment and in situ angulation control, while avoiding windsocking and bird-beaking.

By Giovanni B. Torsello, MD; Martin Austermann, MD; and Giovanni F. Torsello, MD, BA

Precision and Accuracy in the Distal Landing Zone

A case report demonstrating the precise deployment qualities of the GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System.

By Hence J.M. Verhagen, MD, PhD; Sander ten Raa, MD, PhD; and Marie Josee van Rijn, MD, PhD

Early Results and Lessons Learned With the GORE® TAG® Conformable Thoracic Stent Graft With ACTIVE CONTROL System

Device-related factors that are designed to overcome the existing limitations in TEVAR.

By Dittmar Böckler, MD; Moritz S. Bischoff, MD; Vera Zipse, BSc; and Philipp Geisbüsch, MD

LSA Preservation During TEVAR: Insights From the International GREAT Registry

An overview of our experience with the Conformable GORE® TAG® Thoracic Endoprosthesis.

By Dennis R. Gable, MD; and William T. Brinkman, MD

Optimizing TEVAR Outcomes in Acute and Subacute Type B Aortic Dissections

Procedural planning and intraoperative techniques to increase the likelihood of success.

By Bruce Tjaden, MD; and Ali Azizzadeh, MD, FACS

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.